Pfizer To Stop Advertising Celebrex Pain Reliever To Consumers - KLTV.com - Tyler, Longview, Jacksonville |ETX News

Pfizer To Stop Advertising Celebrex Pain Reliever To Consumers

 Drug maker Pfizer says it will no longer advertise its best-selling arthritis pain reliever Celebrex to consumers. This, after a study showed high doses of it were associated with an increased heart attack risk.

A company spokeswoman tells The New York Times the move covers television, radio, newspaper and magazine advertising.

The F-D-A says it agrees with Pfizer's decision. The federal agency was considering warning labels for Celebrex or withdrawing the drug from the U-S market.

Pfizer says it plans to keep Celebrex on the market and will continue marketing the drug to doctors.

Pfizer says Celebrex has not been shown to be dangerous to arthritis patients when taken at normal doses. The heart attack risk in the study disclosed Friday occurred when patients took the drug at two to four times the usual dose for many months.

Copyright 2004 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Powered by Frankly